Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4ZCW

Structure of Human Enolase 2 in complex with SF2312

Summary for 4ZCW
Entry DOI10.2210/pdb4zcw/pdb
Related4ZA0
DescriptorGamma-enolase, [(3S,5S)-1,5-dihydroxy-2-oxopyrrolidin-3-yl]phosphonic acid, MAGNESIUM ION, ... (4 entities in total)
Functional Keywordsenolase gamma, glycolysis, neuron specific enolase, inhibitor, lyase-lyase inhibitor complex, lyase/lyase inhibitor
Biological sourceHomo sapiens (Human)
Cellular locationCytoplasm : P09104
Total number of polymer chains2
Total formula weight96789.93
Authors
Leonard, P.G.,Maxwell, D.,Czako, B.,Muller, F.L. (deposition date: 2015-04-16, release date: 2016-07-20, Last modification date: 2023-09-27)
Primary citationLeonard, P.G.,Satani, N.,Maxwell, D.,Lin, Y.H.,Hammoudi, N.,Peng, Z.,Pisaneschi, F.,Link, T.M.,Lee, G.R.,Sun, D.,Prasad, B.A.,Di Francesco, M.E.,Czako, B.,Asara, J.M.,Wang, Y.A.,Bornmann, W.,DePinho, R.A.,Muller, F.L.
SF2312 is a natural phosphonate inhibitor of enolase.
Nat.Chem.Biol., 12:1053-1058, 2016
Cited by
PubMed Abstract: Despite being crucial for energy generation in most forms of life, few if any microbial antibiotics specifically inhibit glycolysis. To develop a specific inhibitor of the glycolytic enzyme enolase 2 (ENO2) for the treatment of cancers with deletion of ENO1 (encoding enolase 1), we modeled the synthetic tool compound inhibitor phosphonoacetohydroxamate (PhAH) into the active site of human ENO2. A ring-stabilized analog of PhAH, in which the hydroxamic nitrogen is linked to Cα by an ethylene bridge, was predicted to increase binding affinity by stabilizing the inhibitor in a bound conformation. Unexpectedly, a structure-based search revealed that our hypothesized backbone-stabilized PhAH bears strong similarity to SF2312, a phosphonate antibiotic of unknown mode of action produced by the actinomycete Micromonospora, which is active under anaerobic conditions. Here, we present multiple lines of evidence, including a novel X-ray structure, that SF2312 is a highly potent, low-nanomolar inhibitor of enolase.
PubMed: 27723749
DOI: 10.1038/nchembio.2195
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.992 Å)
Structure validation

227111

건을2024-11-06부터공개중

PDB statisticsPDBj update infoContact PDBjnumon